To Evaluate if the Medication Gabapentin Lessens Vulvar Pain
Stopped early · Not applicable · Has a placebo group
Conditions studied: Vulvar Pain Symptoms, Vulvodynia (Chronic Vulvar Pain)
In brief
The purpose of this research study is to evaluate if the medication gabapentin lessens the vulvar pain some women experience.
Key facts
- Study ID
- NCT00390013
- Run by
- Colleen Stockdale
- People needed
- 9
- Starts
- 2007-01-01
- Expected to finish
- 2008-03-01
- Last updated by the study team
- 2017-07-31
Who can join
Age: 18 and older, up to 80. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- All women, ages 18 years and older with the diagnosis of vulvodynia or VVS (by Friedrich's criteria), who present to the University of Iowa Vulvar Vaginal Disease Clinic.
You may not qualify if…
- Vulvar Vaginal Disease clinic patients who are pregnant, less than 3 months postpartum, breast-feeding, non-English speaking, or have contraindication to use of gabapentin due to allergy or renal disease (serum creatinine level greater than 1.4).
Where it is running
- University of Iowa Hospital and Clinics — Iowa City, Iowa, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.